Allianz Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Allianz Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,734	Closed	-$458K	–	2016
2020 Q3	$458K	Sell	8,734 -245,643	-97%	-$10.2M	﹤0.01%	1625
2020 Q2	$8.46M	Buy	254,377 +56,708	+29%	+$1.81M	0.01%	970
2020 Q1	$5.38M	Buy	197,669 +34,091	+21%	+$949K	0.01%	1137
2019 Q4	$3.23M	Buy	+163,578	New	+$2.62M	﹤0.01%	1675
2014 Q3	–	Sell	-102,095	Closed	-$1.23M	–	2399
2014 Q2	$1.23M	Sell	102,095 -10,545	-9%	-$125K	﹤0.01%	1341
2014 Q1	$1.31M	Hold	112,640	–	–	﹤0.01%	1330
2013 Q4	$1.99M	Hold	112,640	–	–	﹤0.01%	1212
2013 Q3	$1.62M	Buy	+112,640	New	+$1.72M	﹤0.01%	1247

Allianz Asset Management's MNTA Position: Q4 2020 in Review

Allianz Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 8,734 shares — an estimated $458K sold.

Allianz Asset Management first reported a position in MNTA in Q3 2013 and held it in 8 quarters. The position peaked at $8.46M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Allianz Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Allianz Asset Management sold 8,734 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $458K.
Allianz Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 8 quarters.
Allianz Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $8.46M in Q2 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.